Legal Representation
Attorney
Kathryn M. Eyster
USPTO Deadlines
Next Deadline
1210 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-12-18)
Due Date
December 18, 2028
Grace Period Ends
June 18, 2029
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 24, 2025 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | Loading... |
| Apr 24, 2025 | C75A | O | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | Loading... |
| Apr 21, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Dec 11, 2024 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED | Loading... |
| Feb 22, 2019 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Feb 4, 2019 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Feb 4, 2019 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Jan 17, 2019 | GPAR | P | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | Loading... |
| Dec 18, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 2, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 29, 2018 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Sep 12, 2018 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Sep 12, 2018 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Sep 12, 2018 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Aug 26, 2018 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 23, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 10, 2018 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Aug 6, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 2, 2018 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 041
Publication of printed matter with the results of clinical studies involving pharmaceutical preparations
Class 042
Medical and scientific research in the field of diabetes, cardiovascular diseases, chronic kidney disease and epidemiological studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Classification
International Classes
041
042